Experimental comparisons of modified IGF-I molecules.
What to look for. LR3, DES, native IGF-I and prescription mecasermin are different materials. Read the identity and model before transferring a result.
IGF-1 LR3 is a modified insulin-like growth factor-I analog. Researchers examine how altered binding-protein interactions change biological activity, including blood-glucose responses in experimental models.
Evidence in this guide: Animal comparisons of IGF variants; LR3 differs from native IGF-I and prescription mecasermin.
Read the IGF-1 LR3 guide ↗IGF-1 DES is the shortened Des(1–3) form of IGF-I. Studies compare its biological effects with native IGF-I and other analogs, including their effects on blood glucose.
Evidence in this guide: Animal analog-comparison studies; DES and LR3 are separate molecules.
Read the IGF-1 DES guide ↗